Exits

Name	Description	Event	Date	Acquired By
	Developing new class of therapeutic compounds.	Acquired	2007
	Pioneering a new era of in vivo imaging.	Acquired	2010
	Developing and manufacturing revolutionary, low-cost, high-performance flow cytometers for researchers.	Acquired	2011
	Internet-based medical monitoring systems for patients with chronic diseases	Acquired	2007
Anesta Corporation	Powerful drug system to control the severe pain of end stage cancer	Acquired	2000
	Developing small molecule therapeutics for multiple oncology and immunology-based indications	Acquired	2010
	Pioneer in the design, marketing and licensing of intelligent solid-state lighting systems	Acquired	2007
	Developing novel therapeutics to promote vascular repair.	Acquired	2012
	Developing resolvins, a novel class of therapies to treat inflammatory diseases and their complications.	Acquired	2011
	Pioneer and global market leader in brain monitoring and measurement products	Acquired	2010
	Developing novel protein measurement systems based on Protien Epitope Tag technology	Acquired	2009
	Software to enable applications transparent use of cluster supercomputers	Acquired	2009
	Machine intelligence for video security	Acquired	2008	Tyco International
	Platform technology enabling novel therapies for treatment of sleep disorders	Acquired	2007
	Genetically diverse organisms for agricultural, life science, and pharmaceutical use	Acquired	2007
	Leading global travel information and advice destination on the web	Acquired	2004
	Large repository of human DNA, serum and tissue samples linked to detailed clinical information	Acquired	2006
	Developmental biology insights for regenerative medicine therapies	Acquired	2000
AudioLogic, Inc.	High performance digital signal processing systems	Acquired	1999
Somatogen	Synthetic hemoglobin products for use in blood transfusion	Acquired	1998

Flagship Ventures

Exits